Press release
Impact Of Coronary Heart Disease On Drug-Eluting Stent Market: An Emerging Driver Transforming The Drug Eluting Stent Market Landscape
Drug Eluting Stent Market Size
What Is the Projected Growth of the Drug Eluting Stent Market?
The drug eluting stent market size has grown strongly in recent years. It is expected to rise from $7.63 billion in 2024 to $8.29 billion in 2025, at a compound annual growth rate (CAGR) of 8.6%. This growth is driven by the demand for better treatment options, clinical evidence, regulatory approvals, healare economics, and medical guidelines.
The drug-eluting stent market is projected to grow to $11.37 billion by 2029, with a CAGR of 8.2%. Growth is supported by an aging population, the expansion of indications, healare reimbursement policies, global market expansion, and patient-centered care. Key trends include personalized medicine, minimally invasive techniques, emerging healare technologies, and next-generation drug formulations.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15557
What Are the Different Drug Eluting Stent Market Segments?
The drug eluting stent market covered in this report is segmented -
1) By Product: Polymer-Based, Polymer-Free
2) By Drug: Sirolimus, Paclitaxel, Zotarolimus, Everolimus, Biolimus, Other Drugs
3) By Scaffold: Cobalt-Chromium, Platinum-Chromium, Nitinol, Biodegradable, Other Scaffolds
4) By Application: Coronary Diseases, Peripheral Vascular Diseases
5) By End-User: Hospitals, Specialty Clinic
Subsegments:
1) By Polymer-Based: Durable Polymer Drug-Eluting Stents, Biodegradable Polymer Drug-Eluting Stents
2) By Polymer-Free: Bare-Metal Stents With Drug Coating, Other Polymer-Free Drug-Eluting Stents
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15557&type=smp
What Are the Primary Drivers Shaping the Drug Eluting Stent Market?
The increasing incidence of coronary heart disease supports the drug-eluting stent market. This condition stems from artery blockages and is rising with aging and sedentary lifestyles. Drug-eluting stents treat it by keeping arteries open and releasing medication. CDC data showed that coronary heart disease in U.S. adults rose from 4.6% in 2020 to 4.9% in 2022. This growing disease burden is promoting the drug-eluting stent market.
Which Companies Are Leading in the Drug Eluting Stent Market?
Major companies operating in the drug eluting stent market are Johnson & Johnson Services Inc., Abbott, Medtronic plc, Boston Scientific Corporation, Terumo Corporation, InspireMD Inc., B. Braun Melsungen AG, Cook Group Incorporated, Lepu Medical Technology (Beijing) Co. Ltd., Biotronik, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, Biosensors International Group Ltd., OrbusNeich Medical Company Limited, Alvimedica Medical Technologies, Hexacath, Elixir Medical Corporation, Translumina GmbH, Cardionovum GmbH, QualiMed Innovative Medizinprodukte GmbH, InSitu Technologies Inc., Acrostak AG, SINOMED Innovation Inc., Svelte Medical Systems Inc.
What Are the Major Trends Shaping the Drug Eluting Stent Market?
In the drug-eluting stent market, companies are developing advanced delivery systems like dual-layer balloons to improve precision in drug delivery and stent deployment. For example, in August 2022, Medtronic launched the Onyx Frontier, a new generation of drug-eluting coronary stent systems featuring a dual-layer balloon, which improves deliverability and patient outcomes.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/drug-eluting-stent-global-market-report
What Are the Top Revenue-Generating Geographies in the Drug Eluting Stent Market?
North America was the largest region in the drug-eluting stent market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug eluting stent market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Drug Eluting Stent Market?
2. What is the CAGR expected in the Drug Eluting Stent Market?
3. What Are the Key Innovations Transforming the Drug Eluting Stent Industry?
4. Which Region Is Leading the Drug Eluting Stent Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Impact Of Coronary Heart Disease On Drug-Eluting Stent Market: An Emerging Driver Transforming The Drug Eluting Stent Market Landscape here
News-ID: 4037533 • Views: …
More Releases from The Business Research Company
Salivary Gland Infection Market Anticipated To Witness Robust Growth, Surpassing …
We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.
What Is the Current Salivary Gland Infection Market Size and Its Estimated Growth Rate?
The market for salivary gland infections has seen robust growth in the past few years. It is projected to expand from $4.12 billion in 2024 to $4.46 billion in 2025, with a compound annual growth rate (CAGR) of…
Global Respiratory Syncytial Virus (RSV) Diagnostics Market Analysis 2025-2030: …
We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.
How Big Is the Respiratory Syncytial Virus (RSV) Diagnostics Market Size Expected to Be by 2034?
In recent times, the market size of Respiratory Syncytial Virus (RSV) diagnostics has seen considerable growth. The market value, which stood at $1.01 billion in 2024, is projected to increase to $1.12 billion in 2025, exhibiting…
Prostate Health Market Size Projected To Reach 53.25 Billion By 2034 With A Cagr …
We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.
What Is the Projected Growth of the Prostate Health Market?
The market size for prostate health has seen a significant surge in growth recently. The increase from $34.07 billion in 2024 to $37.34 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 9.6%, alludes to this fact. The growth during…
Strong Growth Ahead: Pediatric Drugs Market Size To Grow At Arecord 14.9% Cagr B …
We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.
How Big Is the Pediatric Drugs Market Size Expected to Be by 2034?
The size of the pediatric drugs market has seen swift expansion in the past few years. The market, valued at $157.0 billion in 2024, is projected to reach $181.02 billion in 2025, growing at a compound annual growth rate…
More Releases for Drug
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Indispensable Advent of Microcapsules
1.1 Trajectory of Microencapsulation
1.2 Why and wherefores for Microencapsulation
2. Characterization of Microcapsules
2.1 Composition of Microcapsules
2.2 Parameters Influencing Microcapsules
3. Engineering Technology of Microcapsules
3.1 Physical Manufacturing Technologies
3.2 Physicochemical and Chemical Technologies
4. Applicability of Microcapsules
4.1 Microcapsules in Pharmaceuticals
4.2 Microcapsules in Nutraceuticals
…
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug
European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning…
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June.
The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug…
